BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
Abstract:
The present invention is directed to bispecific, heterodimeric checkpoint antibodies.
Information query
Patent Agency Ranking
0/0